Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
Subscribe To Our Newsletter & Stay Updated
